This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignees: Jiangsu Hengrui Medicine Company Ltd., Shanghai Hengrui Pharmaceutical. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Huaide Dong - Innovator in Pharmaceutical Chemistry
Introduction
Huaide Dong is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative therapeutic agents. His work focuses on the design and application of chemical compounds that can be used in the treatment of various diseases.
Latest Patents
Huaide Dong holds a patent for "Substituted morpholines as ATR kinase inhibitors." This invention discloses a pyrazolo-heteroaryl derivative, along with its preparation method and medical applications. The patent specifically relates to the use of this derivative as a therapeutic agent, particularly as an ATR kinase inhibitor, which is crucial in the preparation of drugs aimed at treating and preventing hyperproliferative diseases. The details of the general formula (I) and the definition of each group are thoroughly outlined in the specification.
Career Highlights
Throughout his career, Huaide Dong has worked with notable companies in the pharmaceutical industry. He has been associated with Jiangsu Hengrui Medicine Co., Ltd. and Shanghai Hengrui Pharmaceutical, where he has contributed to various research and development projects. His expertise in medicinal chemistry has positioned him as a valuable asset in these organizations.
Collaborations
Huaide Dong has collaborated with several professionals in his field, including Weikang Tao and Fei Li. These collaborations have enhanced his research efforts and have led to advancements in the development of new therapeutic agents.
Conclusion
Huaide Dong is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in the treatment of diseases. His innovative approach and dedication to research continue to impact the field positively.